• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

FAQ’s: CTEPH, Blood Clots, Corrective Surgery, PAH Centers

September 8, 2017 By Dr. Jeremy Feldman

Dr. Jeremy Feldman

Your Questions Answered Who should be worried about CTEPH? Chronic Thromboembolic Pulmonary Hypertension (CTEPH) develops when blood clots accumulate in the lungs (pulmonary arteries).  Most patients that develop blood clots in the lungs are able to dissolve these clots with the help of blood thinners.  However, some patients may never be aware that they have had a blood clot … [Read more...]

September 2017 Update on Clinical Research Studies for PAH

September 1, 2017 By Dr. Jeremy Feldman

Update on PAH Treatments

Despite tremendous progress over the past 20 years, PAH remains an incurable disease. Only through ongoing clinical research trials will we continue to advance the care of PAH patients. Below I highlight some of the ongoing and soon to begin research studies for PAH. Ralinepag This is a molecule that is similar to Uptravi (Selexipag). The phase 2 study was recently completed … [Read more...]

When Should I feel Better After Starting PAH Treatment?

August 22, 2017 By Dr. Jeremy Feldman

pah biking

This is a very important question.   Patients with PAH are often very frustrated by feeling poorly, often for one to two years prior to formal diagnosis with PAH.  Once the secure diagnosis is made and treatment is started there is a sense of urgency for both patients and doctors to see tangible evidence of improvement.  Improvement is measured in many different ways.  You may … [Read more...]

Oxygen Saturation and Breathlessness in PAH

August 17, 2017 By Dr. Jeremy Feldman

pulse oximeter used for six minute walk

I can’t breathe! I feel short of breath all of the time. We hear these statements every day at PAH specialty centers. We take vital signs of blood pressure, heart rate, respiration rate and oxygen saturation and patients are always surprised if their oxygen saturations are within normal limits.  Read below to learn more. What is oxygen saturation? Oxygen saturation measures … [Read more...]

Increased Interest in PAH: What it Means for Patients

July 24, 2017 By Dr. Jeremy Feldman

pah pills

As more and more treatments become available for PAH and more patients are diagnosed and living with this chronic and progressive disease, there seems to be more and more news of biopharmaceutical companies jumping on board to develop and eventually sell treatments for PH.  It seems nearly every day there is a headline stating companies have merged or been purchased or even … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Researching PH treatments

Scrotal Edema

By Dr. Jeremy Feldman

Swelling of the Scrotum with Pulmonary Arterial Hypertension. We recently received a great question about scrotal edema

high risk vs. low risk life expectancy in Pulmonary Hypertension

Pulmonary Arterial Hypertension Life Expectancy & Survival Rates

By Dr. Jeremy Feldman

The treatment for Pulmonary Arterial Hypertension has come a long way since the mid 1990’s when Flolan was first

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives